These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 22348897)

  • 1. Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis.
    Avni T; Leibovici L; Gafter-Gvili A
    Eur J Heart Fail; 2012 Apr; 14(4):423-9. PubMed ID: 22348897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron Supplementation Improves Cardiovascular Outcomes in Patients with Heart Failure.
    Zhou X; Xu W; Xu Y; Qian Z
    Am J Med; 2019 Aug; 132(8):955-963. PubMed ID: 30853478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.
    Okonko DO; Grzeslo A; Witkowski T; Mandal AK; Slater RM; Roughton M; Foldes G; Thum T; Majda J; Banasiak W; Missouris CG; Poole-Wilson PA; Anker SD; Ponikowski P
    J Am Coll Cardiol; 2008 Jan; 51(2):103-12. PubMed ID: 18191732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of iron therapy in patients with chronic heart failure and iron deficiency: a systematic review and meta-analysis based on 15 randomised controlled trials.
    Zhang J; Hu S; Jiang Y; Zhou Y
    Postgrad Med J; 2020 Dec; 96(1142):766-776. PubMed ID: 32843482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D Supplementation in the Treatment of Chronic Heart Failure: A Meta-analysis of Randomized Controlled Trials.
    Jiang WL; Gu HB; Zhang YF; Xia QQ; Qi J; Chen JC
    Clin Cardiol; 2016 Jan; 39(1):56-61. PubMed ID: 26415519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of iron deficiency in chronic heart failure].
    Uskach TM
    Ter Arkh; 2022 May; 94(4):572-578. PubMed ID: 36286810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of patients with chronic heart failure and iron deficiency treated with intravenous iron: a meta-analysis.
    Kapoor M; Schleinitz MD; Gemignani A; Wu WC
    Cardiovasc Hematol Disord Drug Targets; 2013 Mar; 13(1):35-44. PubMed ID: 23030476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferric carboxymaltose in patients with heart failure and iron deficiency.
    Anker SD; Comin Colet J; Filippatos G; Willenheimer R; Dickstein K; Drexler H; Lüscher TF; Bart B; Banasiak W; Niegowska J; Kirwan BA; Mori C; von Eisenhart Rothe B; Pocock SJ; Poole-Wilson PA; Ponikowski P;
    N Engl J Med; 2009 Dec; 361(25):2436-48. PubMed ID: 19920054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of drug and exercise intervention on functional capacity and quality of life in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials.
    Fukuta H; Goto T; Wakami K; Ohte N
    Eur J Prev Cardiol; 2016 Jan; 23(1):78-85. PubMed ID: 25520380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials.
    Jankowska EA; Tkaczyszyn M; Suchocki T; Drozd M; von Haehling S; Doehner W; Banasiak W; Filippatos G; Anker SD; Ponikowski P
    Eur J Heart Fail; 2016 Jul; 18(7):786-95. PubMed ID: 26821594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of intravenous and oral iron supplements for the treatment of iron deficiency in patients with heart failure: A network meta-analysis of randomized controlled trials.
    Mei Z; Chen J; Luo S; Jin L; Liu Q; Chen Y
    Pharmacol Res; 2022 Aug; 182():106345. PubMed ID: 35810949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous iron without erythropoietin for the treatment of iron deficiency anemia in patients with moderate to severe congestive heart failure and chronic kidney insufficiency.
    Usmanov RI; Zueva EB; Silverberg DS; Shaked M
    J Nephrol; 2008; 21(2):236-42. PubMed ID: 18446719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anemia in heart failure: should we supplement iron in patients with chronic heart failure?
    Kaldara-Papatheodorou EE; Terrovitis JV; Nanas JN
    Pol Arch Med Wewn; 2010 Sep; 120(9):354-60. PubMed ID: 20864909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized comparison of 5 versus 12 hours per day of cardiac contractility modulation treatment for heart failure patients: A preliminary report.
    Kloppe A; Mijic D; Schiedat F; Bogossian H; Mügge A; Rousso B; Lemke B
    Cardiol J; 2016; 23(1):114-9. PubMed ID: 26503077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of intravenous ferric carboxymaltose on red cell distribution width: a subanalysis of the FAIR-HF study.
    Van Craenenbroeck EM; Conraads VM; Greenlaw N; Gaudesius G; Mori C; Ponikowski P; Anker SD
    Eur J Heart Fail; 2013 Jul; 15(7):756-62. PubMed ID: 23639779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of iron supplementation in patients with heart failure and iron deficiency: a meta-analysis.
    Zhang S; Zhang F; Du M; Huang K; Wang C
    Br J Nutr; 2019 Apr; 121(8):841-848. PubMed ID: 30782220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous versus oral iron supplementation for the treatment of anemia in CKD: systematic review and meta-analysis.
    Rozen-Zvi B; Gafter-Gvili A; Paul M; Leibovici L; Shpilberg O; Gafter U
    Am J Kidney Dis; 2008 Nov; 52(5):897-906. PubMed ID: 18845368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.
    Pfisterer M; Buser P; Rickli H; Gutmann M; Erne P; Rickenbacher P; Vuillomenet A; Jeker U; Dubach P; Beer H; Yoon SI; Suter T; Osterhues HH; Schieber MM; Hilti P; Schindler R; Brunner-La Rocca HP;
    JAMA; 2009 Jan; 301(4):383-92. PubMed ID: 19176440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of quality of life of patients with heart failure and iron deficiency treated with ferric carboxymaltose: FAIR-HF sub-analysis.
    Gutzwiller FS; Pfeil AM; Comin-Colet J; Ponikowski P; Filippatos G; Mori C; Braunhofer PG; Szucs TD; Schwenkglenks M; Anker SD
    Int J Cardiol; 2013 Oct; 168(4):3878-83. PubMed ID: 23870642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.